Welcome to our dedicated page for Parkervision news (Ticker: PRKR), a resource for investors and traders seeking the latest updates and insights on Parkervision stock.
ParkerVision, Inc. develops and licenses proprietary radio-frequency technologies for wireless applications and markets technologies and products used in advanced wireless communication systems. Company news centers on its RF patent portfolio, licensing strategy, and U.S. patent enforcement actions, including appellate and district-court proceedings involving wireless-technology claims.
Recurring updates also include quarterly and year-end operating results, capital actions such as registered direct common stock offerings, and corporate developments tied to litigation funding, intellectual-property strategy, and governance. The company trades on the OTCQB under the symbol PRKR.
ParkerVision (OTCQB:PRKR) appointed Anthony (Tony) Bowers as a Class II director, filling the board vacancy created by the May 15, 2026 retirement of Lewis H. Titterton Jr.
Bowers brings 30+ years of corporate and institutional sales experience, including roles at Goldman Sachs and OTR Global.
ParkerVision (OTCQB:PRKR) reported Q1 2026 results and litigation updates on May 7, 2026. The company posted a net loss of $1.6 million (basic/diluted loss per share $0.01) and ended the quarter with $3.4 million cash. Contingent payment obligations were $46.49 million.
Litigation developments: the CAFC set expedited appellate oral arguments for June 1, 2026 in the Qualcomm appeal; trials vs. MediaTek and Realtek were postponed with amended expert-report deadlines in May–June 2026.
ParkerVision (OTCQB:PRKR) announced the Court of Appeals for the Federal Circuit set oral arguments for June 1, 2026 in its expedited appeal of the district court decision in ParkerVision v. Qualcomm.
The company also reported two Western District of Texas cases (MediaTek, Realtek) had trials postponed and proposed resubmission of expert reports by May 2026, close of expert discovery by June 2026, and final pre-trial briefings by July 2026. New trial dates remain pending.
ParkerVision (OTCQB:PRKR) completed appellate briefing on April 4, 2026, appealing the Orlando district court's claim construction that led to a non-infringement stipulation and judgment.
ParkerVision says Qualcomm's Federal Circuit brief contains a contradiction that undermines the prior issue-preclusion basis; ParkerVision asks the Federal Circuit to reverse and remand for trial.
ParkerVision (OTCQB:PRKR) reported year ended December 31, 2025 results, posting a net loss of $7.4M ($0.06/sh) versus a $14.5M loss in 2024 ($0.16/sh). Cash was $4.4M with ~$2.3M working capital. Key legal developments include an expedited CAFC appeal schedule in ParkerVision v. Qualcomm and a postponed MediaTek trial pending updated expert reports.
The company recognized a $0.6M fair-value gain on contingent payment obligations in 2025 versus a $9.6M loss in 2024 and completed a registered direct offering raising ~$4.5M in November 2025.
ParkerVision (OTCQB:PRKR) announced the jury trial in its patent infringement action against MediaTek, originally set for March 20, 2026 in Waco, Texas, has been postponed.
Judge Albright reviewed a Daubert motion on March 16, 2026; the Court took the trial off calendar pending updated expert reports and briefing, and will issue a revised pretrial and trial schedule after submissions.
ParkerVision (OTCQB:PRKR) said the jury trial in its patent infringement action against MediaTek will commence on March 20, 2026 in Waco, Texas, with jury selection the preceding day.
The trial had been scheduled to start March 23, 2026; the district court changed the start date at its request. The company noted its ongoing patent licensing and enforcement efforts and provided investor contacts.
ParkerVision (OTCQB: PRKR) filed its opening brief in its expedited appeal to the Court of Appeals for the Federal Circuit in ParkerVision v. Qualcomm and said the CAFC reinstated an expedited briefing schedule on January 21, 2026.
The schedule set ParkerVision's opening brief due Feb 4, 2026, Qualcomm's response due Mar 16, 2026, and ParkerVision's final reply seven days later; oral argument will follow briefing. The company also requested reassignment and noted two upcoming trials: MediaTek on Mar 23, 2026, and a combined Realtek trial on Apr 27, 2026.
ParkerVision (OTCQB:PRKR) closed a registered direct offering on November 24, 2025, selling 16,481,579 shares of common stock at $0.21 per share for gross proceeds of approximately $3.46 million.
The sale was completed under a Shelf registration declared effective by the SEC on May 28, 2025. Including a $1.0 million common stock purchase by a director on November 17, 2025, the company has raised an aggregate of about $4.46 million under the Shelf.
ParkerVision (OTCQB:PRKR) closed a registered direct offering on November 17, 2025, selling 4,761,905 shares of common stock to independent director Lewis H. Titterton, Jr. at $0.21 per share for gross proceeds of $1,000,000.
The per-share price matched the last reported sale price on November 14, 2025. The shares were issued under the Company’s shelf registration filed April 2025 and declared effective by the SEC on May 28, 2025; this is the first transaction completed under that Shelf.
The company describes its business as developing and licensing RF technologies and notes ongoing U.S. patent enforcement actions. Contact information for CFO Cindy French and Communications Director Tony Vignieri is provided.